CIK 0001374339 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
ProMIS Neurosciences Inc.
Sign in to watch- Ticker
- PMN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Canada (Federal Level)
- Entity type
- operating
- Phone
- 416-847-6898
- Business address
- SUITE 200, 1920 YONGE STREET, TORONTO, Ontario, Canada, M4S 3E2
- Former names
- AMORFIX LIFE SCIENCES LTD
- Open-market buys, last 90 days
- $134,746
- in 3 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$134,746. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-12 | Kirwin Patrick D. Director | Grant or award · Option (right to buy) | +20,000 | 20,000 | ||
| 2025-06-12 | Shafmaster Madge K. Director | Grant or award · Option (right to buy) | +20,000 | 20,000 | ||
| 2025-06-12 | WYMAN WILLIAM W Director | Grant or award · Option (right to buy) | +20,000 | 20,000 | ||
| 2025-06-12 | Williams Eugene Director | Grant or award · Option (right to buy) | +20,000 | 20,000 | ||
| 2025-03-13 | GORDON MICHAEL S See Remarks section. | Other disposition | −48,333 | 0 | ||
| 2025-02-10 | Cashman Neil Chief Scientific Officer | Purchase | +15,000 | $0.97 | $15K | 16,617 |
| 2024-11-18 | Milbury Max A. Principal Accounting Officer | Grant or award · Option (right to buy) | +70,000 | 70,000 | ||
| 2024-11-18 | Kaplan Johanne Chief Development Officer | Grant or award · Option (right to buy) | +175,000 | 175,000 | ||
| 2024-11-18 | Cashman Neil Chief Scientific Officer | Grant or award · Option (right to buy) | +200,000 | 200,000 | ||
| 2024-11-18 | ALTSTIEL LARRY DOUGLAS Chief Medical Officer | Grant or award · Option (right to buy) | +175,000 | 175,000 | ||
| 2024-10-08 | Warma Neil K Chief Executive Officer | Grant or award · Option (right to buy) | +1,144,122 | 1,352,455 | ||
| 2024-10-08 | Warma Neil K Chief Executive Officer | Grant or award · Option (right to buy) | +490,338 | 1,842,739 | ||
| 2024-10-03 | WYMAN WILLIAM W Director | Grant or award · Option (right to buy) | +40,000 | 40,000 | ||
| 2024-10-03 | Williams Eugene Director | Grant or award · Option (right to buy) | +40,000 | 40,000 | ||
| 2024-10-03 | Shafmaster Madge K. Director | Grant or award · Option (right to buy) | +40,000 | 40,000 | ||
| 2024-10-03 | Mandel-Brehm Josh Director | Grant or award · Option (right to buy) | +40,000 | 40,000 | ||
| 2024-10-03 | Kirwin Patrick D. Director | Grant or award · Option (right to buy) | +40,000 | 40,000 | ||
| 2024-09-24 | Shafmaster Madge K. Director | Purchase | +70,000 | $1.30 | $91K | 208,333 |
| 2024-09-23 | Shafmaster Madge K. Director | Purchase | +70,000 | $1.28 | $90K | 138,333 |
| 2024-09-20 | Shafmaster Madge K. Director | Purchase | +60,000 | $1.25 | $75K | 68,333 |
Page 5 of 8 · 158 trades